Sanofi and Regeneron cut list price of cholesterol drug by 60 percent

72

Sanofi SA and Regeneron Pharmaceuticals Inc said on Monday that they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent, as the drugmakers follow a similar move by rival Amgen Inc in hopes of increasing use of the drug.

http://feeds.reuters.com/~r/reuters/healthNews/~3/_idMYRfXDKA/sanofi-and-regeneron-cut-list-price-of-cholesterol-drug-by-60-percent-idUSKCN1Q019M